Fachschaft Pharmazie

“Drug Discovery in Academia: Some Success Stories” – Vortrag von Prof. Michael E. Jung

The process of drug discovery in academia will be discussed with several examples of prior and ongoing collaborations, with some success stories.
Main focus will be on the two compounds from his lab, which has been approved and are on the market:
1) Xtandi, approved 8/31/12 for the treatment of castration-resistant prostate cancer (CRPC), and
2) Erleada, approved 2/14/18 for the treatment of non-metastatic CRPC.


07 Nov 2018


18:15 - 20:00


Hörsaal N4
Hörsaalzentrum Morgenstelle Uni Tübingen, 72076 Tübingen


Prof. Koch & Prof. Laufer
Menü schließen